Adaptive clinical trials in oncology

Prediction of survival benefits from progression-free survival in patients with advanced non small cell lung cancer: Evidence from a pooled analysis of 2,838 patients randomized in 7 trials

(2017) M. E. Buyse et al.   JOURNAL OF CLINICAL ONCOLOGY

Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development

(2012) Brenda Gaydos et al.   DRUG INFORMATION JOURNAL

A Historical Perspective on Clinical Trials Innovation and Leadership

(2011) David L. DeMets   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Development of Novel Combination Therapies

(2011) Janet Woodcock et al.   NEW ENGLAND JOURNAL OF MEDICINE

I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

(2009) AD Barker et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center

(2009) Swati Biswas et al.   Clinical Trials

Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival

(2009) Kristine R. Broglio et al.   JNCI-Journal of the National Cancer Institute

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

(2009) Hyman B. Muss et al.   NEW ENGLAND JOURNAL OF MEDICINE

The relationship between progression-free and post-progression survival in treating four types of metastatic cancer

(2008) Russell J. Bowater et al.   CANCER LETTERS

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

(2008) Tomasz Burzykowski et al.   JOURNAL OF CLINICAL ONCOLOGY